Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 26

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Peptide/Receptor Co-evolution Explains the Lipolytic Function of the Neuropeptide TLQP-21

Sahu, Bhavani S., Rodriguez, Pedro, Nguyen, Megin E., Han, Ruijun, Cero, Cheryl, Razzoli, Maria, Piaggi, Paolo, Laskowski, Lauren J., Pavlicev, Mihaela, Muglia, Louis, Mahata, Sushil K., O’Grady, Scott, McCorvy, John D., Baier, Leslie J., Sham, Yuk Y., Bartolomucci, Alessandro · 2019 · Cell Reports

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.celrep.2019.07.101

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 74

  1. Ahmed, 2014, Predicting the molecular interactions of CRIP1a-cannabinoid 1 receptor with integrated molecular modeling approaches, Bioorg. Med. Chem. Lett., 24, 1158, 10.1016/j.bmcl.2013.12.119 · DOI
  2. Arner, 1999, Catecholamine-induced lipolysis in obesity, Int. J. Obes. Relat. Metab. Disord., 23, 10, 10.1038/sj.ijo.0800789 · DOI · Paper page
  3. Bandyopadhyay, 2012, Catestatin (chromogranin A(352-372)) and novel effects on mobilization of fat from adipose tissue through regulation of adrenergic and leptin signaling, J. Biol. Chem., 287, 23141, 10.1074/jbc.M111.335877 · DOI
  4. Bartolomucci, 2006, TLQP-21, a VGF-derived peptide, increases energy expenditure and prevents the early phase of diet-induced obesity, Proc. Natl. Acad. Sci. USA, 103, 14584, 10.1073/pnas.0606102103 · DOI · Paper page
  5. Bartolomucci, 2011, The extended granin family: structure, function, and biomedical implications, Endocr. Rev., 32, 755, 10.1210/er.2010-0027 · DOI · Paper page
  6. Beard, 2013, Applying physics-based scoring to calculate free energies of binding for single amino acid mutations in protein-protein complexes, PLoS ONE, 8, e82849, 10.1371/journal.pone.0082849 · DOI · Paper page
  7. Cero, 2014, The TLQP-21 peptide activates the G-protein-coupled receptor C3aR1 via a folding-upon-binding mechanism, Structure, 22, 1744, 10.1016/j.str.2014.10.001 · doi:10.1016/j.str.2014.10.001
  8. Cero, 2016, The neuropeptide TLQP-21 opposes obesity via C3aR1-mediated enhancement of adrenergic-induced lipolysis, Mol. Metab., 6, 148, 10.1016/j.molmet.2016.10.005 · DOI · Paper page
  9. Chakraborty, 2015, Probing the Conformational Dynamics of the Bioactive Peptide TLQP-21 in Solution: A Molecular Dynamics Study, Chem. Biol. Drug Des., 86, 938, 10.1111/cbdd.12541 · doi:10.1111/cbdd.12541
  10. Chao, 1999, Role of the second extracellular loop of human C3a receptor in agonist binding and receptor function, J. Biol. Chem., 274, 9721, 10.1074/jbc.274.14.9721 · DOI
  11. Clapham, 2011, Targeting thermogenesis and related pathways in anti-obesity drug discovery, Pharmacol. Ther., 131, 295, 10.1016/j.pharmthera.2011.04.004 · DOI
  12. Clemmensen, 2019, Emerging hormonal-based combination pharmacotherapies for the treatment of metabolic diseases, Nat. Rev. Endocrinol., 15, 90, 10.1038/s41574-018-0118-x · DOI
  13. Coulthard, 2015, Is the complement activation product C3a a proinflammatory molecule? Re-evaluating the evidence and the myth, J. Immunol., 194, 3542, 10.4049/jimmunol.1403068 · DOI · Paper page
  14. Doolen, 2017, Complement 3a receptor in dorsal horn microglia mediates pronociceptive neuropeptide signaling, Glia, 65, 1976, 10.1002/glia.23208 · DOI · Paper page
  15. Ember, 1991, Designing synthetic superagonists of C3a anaphylatoxin, Biochemistry, 30, 3603, 10.1021/bi00229a003 · DOI
  16. Falls, 2018, Insights into the Allosteric Mechanism of Setmelanotide (RM-493) as a Potent and First-in-Class Melanocortin-4 Receptor (MC4R) Agonist To Treat Rare Genetic Disorders of Obesity through an in Silico Approach, ACS Chem. Neurosci., 10, 1055, 10.1021/acschemneuro.8b00346 · DOI
  17. Fargali, 2014, The granin VGF promotes genesis of secretory vesicles, and regulates circulating catecholamine levels and blood pressure, FASEB J., 28, 2120, 10.1096/fj.13-239509 · doi:10.1096/fj.13-239509
  18. Gerardy-Schahn, 1988, Design and biological activity of a new generation of synthetic C3a analogues by combination of peptidic and non-peptidic elements, Biochem. J., 255, 209
  19. Granneman, 2008, Location, location: protein trafficking and lipolysis in adipocytes, Trends Endocrinol. Metab., 19, 3, 10.1016/j.tem.2007.10.006 · DOI
  20. Hannedouche, 2013, Identification of the C3a receptor (C3AR1) as the target of the VGF-derived peptide TLQP-21 in rodent cells, J. Biol. Chem., 288, 27434, 10.1074/jbc.M113.497214 · DOI
  21. Hauser, 2017, Trends in GPCR drug discovery: new agents, targets and indications, Nat. Rev. Drug Discov., 16, 829, 10.1038/nrd.2017.178 · DOI · Paper page
  22. Hollmann, 1998, Cloning, expression, sequence determination, and chromosome localization of the mouse complement C3a anaphylatoxin receptor gene, Mol. Immunol., 35, 137, 10.1016/S0161-5890(98)00021-2 · DOI
  23. Hugli, 1978, Anaphylatoxins: C3a and C5a, Adv. Immunol., 26, 1, 10.1016/S0065-2776(08)60228-X · DOI · Paper page
  24. Jethwa, 2007, VGF-derived peptide, TLQP-21, regulates food intake and body weight in Siberian hamsters, Endocrinology, 148, 4044, 10.1210/en.2007-0038 · doi:10.1210/en.2007-0038
  25. Jorgensen, 1983, Comparison of simple potential functions for simulating liquid water, J. Chem. Phys., 79, 926, 10.1063/1.445869 · DOI · Paper page
  26. Jorgensen, 1996, Development and Testing of the OPLS All-Atom Force Field on Conformational Energetics and Properties of Organic Liquids, J. Am. Chem. Soc., 118, 11225, 10.1021/ja9621760 · DOI · Paper page
  27. Klos, 2013, International Union of Basic and Clinical Pharmacology. [corrected]. LXXXVII. Complement peptide C5a, C4a, and C3a receptors, Pharmacol. Rev., 65, 500, 10.1124/pr.111.005223 · DOI · Paper page
  28. Kroeze, 2015, PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome, Nat. Struct. Mol. Biol., 22, 362, 10.1038/nsmb.3014 · DOI · Paper page
  29. Krout, 2017, The TRPC1 Ca2+-permeable channel inhibits exercise-induced protection against high-fat diet-induced obesity and type II diabetes, J. Biol. Chem., 292, 20799, 10.1074/jbc.M117.809954 · DOI
  30. Lafontan, 2009, Lipolysis and lipid mobilization in human adipose tissue, Prog. Lipid Res., 48, 275, 10.1016/j.plipres.2009.05.001 · DOI · Paper page
  31. Lahti, 2012, Bioinformatics and variability in drug response: a protein structural perspective, J. R. Soc. Interface, 9, 1409, 10.1098/rsif.2011.0843 · DOI
  32. Liao, 2014, The TRPC Family of TRP Channels: Roles Inferred (Mostly) from Knockout Mice and Relationship to ORAI Proteins, Handb. Exp. Pharmacol., 223, 1055, 10.1007/978-3-319-05161-1_14 · doi:10.1007/978-3-319-05161-1_14
  33. Liu, 2012, Enhanced store-operated Ca2+ entry and TRPC channel expression in pulmonary arteries of monocrotaline-induced pulmonary hypertensive rats, Am. J. Physiol. Cell Physiol., 302, C77, 10.1152/ajpcell.00247.2011 · DOI
  34. Liu, 2018, Orthosteric and allosteric action of the C5a receptor antagonists, Nat. Struct. Mol. Biol., 25, 472, 10.1038/s41594-018-0067-z · DOI
  35. Lo, 2014, Adipsin is an adipokine that improves β cell function in diabetes, Cell, 158, 41, 10.1016/j.cell.2014.06.005 · DOI · Paper page
  36. Lönnqvist, 1992, Lipolytic catecholamine resistance due to decreased beta 2-adrenoceptor expression in fat cells, J. Clin. Invest., 90, 2175, 10.1172/JCI116103 · DOI
  37. Lotta, 2019, Human Gain-of-Function MC4R Variants Show Signaling Bias and Protect against Obesity, Cell, 177, 597, 10.1016/j.cell.2019.03.044 · DOI · Paper page
  38. Mahata, 1997, Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist, J. Clin. Invest., 100, 1623, 10.1172/JCI119686 · DOI · Paper page
  39. Mamane, 2009, The C3a anaphylatoxin receptor is a key mediator of insulin resistance and functions by modulating adipose tissue macrophage infiltration and activation, Diabetes, 58, 2006, 10.2337/db09-0323 · DOI · Paper page
  40. Mason, 2011, Bimodal distribution of RNA expression levels in human skeletal muscle tissue, BMC Genomics, 12, 98, 10.1186/1471-2164-12-98 · DOI
  41. McCorvy, 2018, Structural determinants of 5-HT2B receptor activation and biased agonism, Nat. Struct. Mol. Biol., 25, 787, 10.1038/s41594-018-0116-7 · DOI · Paper page
  42. Molteni, 2017, Pharmacological and Biochemical Characterization of TLQP-21 Activation of a Binding Site on CHO Cells, Front. Pharmacol., 8, 167, 10.3389/fphar.2017.00167 · DOI
  43. Mowers, 2013, Inflammation produces catecholamine resistance in obesity via activation of PDE3B by the protein kinases IKKε and TBK1, eLife, 2, e01119, 10.7554/eLife.01119 · DOI
  44. Pandey, 2019, Partial ligand-receptor engagement yields functional bias at the human complement receptor, C5aR1, J. Biol. Chem., 294, 9416, 10.1074/jbc.RA119.007485 · DOI
  45. Papadopoulos, 2007, COBALT: constraint-based alignment tool for multiple protein sequences, Bioinformatics, 23, 1073, 10.1093/bioinformatics/btm076 · DOI · Paper page
  46. Pellegrinelli, 2018, Adipocyte-secreted BMP8b mediates adrenergic-induced remodeling of the neuro-vascular network in adipose tissue, Nat. Commun., 9, 4974, 10.1038/s41467-018-07453-x · DOI
  47. Petrocchi Passeri, 2013, Neuropeptide TLQP-21, a VGF internal fragment, modulates hormonal gene expression and secretion in GH3 cell line, Neuroendocrinology, 97, 212, 10.1159/000339855 · doi:10.1159/000339855
  48. Pinilla, 2011, Characterization of the reproductive effects of the anorexigenic VGF-derived peptide TLQP-21: in vivo and in vitro studies in male rats, Am. J. Physiol. Endocrinol. Metab., 300, E837, 10.1152/ajpendo.00598.2010 · DOI
  49. Pirzgalska, 2017, Sympathetic neuron-associated macrophages contribute to obesity by importing and metabolizing norepinephrine, Nat. Med., 23, 1309, 10.1038/nm.4422 · DOI · Paper page
  50. Possenti, 2012, Characterization of a novel peripheral pro-lipolytic mechanism in mice: role of VGF-derived peptide TLQP-21, Biochem. J., 441, 511, 10.1042/BJ20111165 · doi:10.1042/bj20111165
  51. Quell, 2017, Monitoring C3aR Expression Using a Floxed tdTomato-C3aR Reporter Knock-in Mouse, J. Immunol., 199, 688, 10.4049/jimmunol.1700318 · DOI · Paper page
  52. Rapold, 2013, Fas activates lipolysis in a Ca2+-CaMKII-dependent manner in 3T3-L1 adipocytes, J. Lipid Res., 54, 63, 10.1194/jlr.M028035 · DOI
  53. Regal, 2000, Minor role of the C3a receptor in systemic anaphylaxis in the guinea pig, Immunopharmacology, 46, 15, 10.1016/S0162-3109(99)00152-6 · doi:10.1016/s0162-3109(99)00152-6
  54. Regal, 1993, Role of the complement system in antigen-induced bronchoconstriction and changes in blood pressure in the guinea pig, J. Pharmacol. Exp. Ther., 267, 979, 10.1016/S0022-3565(25)39575-3 · doi:10.1016/s0022-3565(25)39575-3
  55. Reid, 2013, Downsizing a human inflammatory protein to a small molecule with equal potency and functionality, Nat. Commun., 4, 2802, 10.1038/ncomms3802 · doi:10.1038/ncomms3802
  56. Reilly, 2017, Adapting to obesity with adipose tissue inflammation, Nat. Rev. Endocrinol., 13, 633, 10.1038/nrendo.2017.90 · DOI · Paper page
  57. Rivolta, 2017, JMV5656, A Novel Derivative of TLQP-21, Triggers the Activation of a Calcium-Dependent Potassium Outward Current in Microglial Cells, Front. Cell. Neurosci., 11, 41, 10.3389/fncel.2017.00041 · DOI
  58. Robertson, 2018, Structure of the complement C5a receptor bound to the extra-helical antagonist NDT9513727, Nature, 553, 111, 10.1038/nature25025 · DOI
  59. Rodgers, 2012, Anti-obesity drugs: past, present and future, Dis. Model. Mech., 5, 621, 10.1242/dmm.009621 · DOI · Paper page
  60. Roglic, 1996, cDNA cloning of a novel G protein-coupled receptor with a large extracellular loop structure, Biochim. Biophys. Acta, 1305, 39, 10.1016/0167-4781(95)00209-X · doi:10.1016/0167-4781(95)00209-x
  61. Sabourin, 2016, Transient Receptor Potential Canonical (TRPC)/Orai1-dependent Store-operated Ca2+ Channels: NEW TARGETS OF ALDOSTERONE IN CARDIOMYOCYTES, J. Biol. Chem., 291, 13394, 10.1074/jbc.M115.693911 · DOI
  62. Sadaghiani, 2014, Identification of Orai1 channel inhibitors by using minimal functional domains to screen small molecule microarrays, Chem. Biol., 21, 1278, 10.1016/j.chembiol.2014.08.016 · DOI
  63. Sexton, 2016, The contribution of TRPC1, TRPC3, TRPC5 and TRPC6 to touch and hearing, Neurosci. Lett., 610, 36, 10.1016/j.neulet.2015.10.052 · DOI
  64. Shah, 2014, Do you know the sex of your cells?, Am. J. Physiol. Cell Physiol., 306, C3, 10.1152/ajpcell.00281.2013 · DOI · Paper page
  65. Shimada, 2019, GPCR drug discovery: integrating solution NMR data with crystal and cryo-EM structures, Nat. Rev. Drug Discov., 18, 59, 10.1038/nrd.2018.180 · DOI · Paper page
  66. Singh, 2010, The transient receptor potential channel antagonist SKF96365 is a potent blocker of low-voltage-activated T-type calcium channels, Br. J. Pharmacol., 160, 1464, 10.1111/j.1476-5381.2010.00786.x · DOI · Paper page
  67. Stephens, 2012, A VGF-derived peptide attenuates development of type 2 diabetes via enhancement of islet β-cell survival and function, Cell Metab., 16, 33, 10.1016/j.cmet.2012.05.011 · doi:10.1016/j.cmet.2012.05.011
  68. Still, 1990, Semianalytical treatment of solvation for molecular mechanics and dynamics, J. Am. Chem. Soc., 112, 6127, 10.1021/ja00172a038 · DOI · Paper page
  69. Sukumar, 2012, Constitutively active TRPC channels of adipocytes confer a mechanism for sensing dietary fatty acids and regulating adiponectin, Circ. Res., 111, 191, 10.1161/CIRCRESAHA.112.270751 · DOI
  70. Sun, 1999, Identification of ligand effector binding sites in transmembrane regions of the human G protein-coupled C3a receptor, Protein Sci., 8, 2304, 10.1110/ps.8.11.2304 · DOI
  71. Tschöp, 2016, Unimolecular Polypharmacy for Treatment of Diabetes and Obesity, Cell Metab., 24, 51, 10.1016/j.cmet.2016.06.021 · DOI · Paper page
  72. Vazquez, 2004, The mammalian TRPC cation channels, Biochim. Biophys. Acta, 1742, 21, 10.1016/j.bbamcr.2004.08.015 · DOI · Paper page
  73. Whittle, 2012, BMP8B increases brown adipose tissue thermogenesis through both central and peripheral actions, Cell, 149, 871, 10.1016/j.cell.2012.02.066 · DOI · Paper page
  74. Zhang, 2005, Homology modeling and molecular dynamics simulations of the mu opioid receptor in a membrane-aqueous system, ChemBioChem, 6, 853, 10.1002/cbic.200400207 · doi:10.1002/cbic.200400207

Cited by

See all 26

Metadata

Authors
Sahu, B. S., Rodriguez, P., Nguyen, M. E., Han, R., Cero, C., Razzoli, M., Piaggi, P., Laskowski, L. J., Pavlicev, M., Muglia, L., Mahata, S. K., O’Grady, S., McCorvy, J. D., Baier, L. J., Sham, Y. Y., & Bartolomucci, A.
Venue
Cell Reports
Publisher
Elsevier BV
Published
2019-09
Volume
28
Issue
10
Pages
2567-2580.e6
ISSN
2211-1247
Cited by
26
References
7
Language
en
Licence
Funders
  • National Institutes of Health (AI128729)
  • National Institute of Diabetes and Digestive and Kidney Diseases (JCSTF-180217, DK117504, / NIDDK DK102496)
  • U.S. Department of Veterans Affairs (BT-/RLF/Re-entry/38/2016, I01BX000323)
  • Department of Biotechnology, Ministry of Science and Technology, India
  • Company of Biologists (JCSTF-180217)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Peptide/Receptor Co-evolution Explains the Lipolytic Function of the Neuropeptide TLQP-21. https://app.cochat.ai/papers/10.1016/j.celrep.2019.07.101
The paper
Sahu, B. S., Rodriguez, P., Nguyen, M. E., Han, R., Cero, C., Razzoli, M., Piaggi, P., Laskowski, L. J., Pavlicev, M., Muglia, L., Mahata, S. K., O’Grady, S., McCorvy, J. D., Baier, L. J., Sham, Y. Y., & Bartolomucci, A. (2019). Peptide/Receptor Co-evolution Explains the Lipolytic Function of the Neuropeptide TLQP-21. Cell Reports. https://doi.org/10.1016/j.celrep.2019.07.101

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.